Glucagon: Exploring Its Role Beyond Emergency Kits
Many patients when diagnosed with Type 1 Diabetes are given glucagon to keep on hand for very low blood sugar emergencies. Dive deeper into the science, nuances, and myths behind glucagon by reading the captivating blog post by Lauren Bongiorno, Founder and CEO of Risely Health, in conversation with Paul R. Edick, Chairman and CEO of Xeris Pharmaceuticals®.
In the article it’s mentioned, “There are 12-15 million insulin dependent people and less than 1 million have a prescription for glucagon. Paul compares that to …people with severe allergies [by stating that] ‘They sell 8 million EpiPens every year…’.” Click the link below to read the full quote and more of the compelling insights that dispel myths surrounding glucagon: https://www.riselyhealth.com/blog/the-truth-about-glucagon-debunking-common-myths-and-misperceptions
Reference: Bongiorno, L., & Edick, P. R. (2024). The Truth About Glucagon: Debunking Common Myths and Misperceptions. Retrieved from https://www.riselyhealth.com/blog/the-truth-about-glucagon-debunking-common-myths-and-misperceptions
